耶鲁-布朗强迫症量表（DY-BOCS）的仅采访版本在寻求治疗的强迫症青年中的验证。,Psychiatry Research

当前位置： X-MOL 学术 › Psychiatry Res. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

耶鲁-布朗强迫症量表（DY-BOCS）的仅采访版本在寻求治疗的强迫症青年中的验证。
Psychiatry Research ( IF 4.2 ) Pub Date : 2018-11-28 , DOI: 10.1016/j.psychres.2018.11.048
Matti Cervin ₁ , Sean Perrin ₂ , Elin Olsson ₃ , Emma Claesdotter-Knutsson ₁ , Magnus Lindvall ₁

Affiliation

越来越多的证据表明，强迫症（OCD）患者可能会沿着不同的症状维度进行亚型化。这些维度可能有助于解释对当前治疗方法的反应。耶鲁-布朗强迫症量表（DY-BOCS）是一种经过验证的工具，包括自我报告筛查工具，然后进行结构化访谈，评估和评定强迫症症状征兆的存在/不存在和严重性。本研究调查了用于常规护理的经修改的DY-BOCS的简短，仅面试版本的有效性。对临床上有强迫症的儿童和青少年（N = 119）进行DY-BOCS以及其他强迫症，焦虑症，抑郁，初次评估后平均14个月，对总体功能和一个子集（N = 100）进行了重新评估。DY-BOCS的这种简短的，仅接受采访的版本显示出高水平的内部一致性，并在中等到强范围内与强迫症（OCD）严重程度和强迫症症状征候的替代度量相关。从基线到随访，DY-BOCS的变化评分与强迫症替代措施和临床医师评价的改善的变化评分显着相关，这表明DY-BOCS的这一简短版本对治疗效果有效且敏感用于常规临床护理中的强迫症。仅限面试的DY-BOCS版本显示出高水平的内部一致性，并与中度至强范围内的强迫症严重程度和强迫症症状尺寸的替代指标相关。从基线到随访，DY-BOCS的变化评分与强迫症替代措施和临床医师评价的改善的变化评分显着相关，这表明DY-BOCS的这一简短版本对治疗效果有效且敏感用于常规临床护理中的强迫症。仅限面试的DY-BOCS版本显示出高水平的内部一致性，并与中度至强范围内的强迫症严重程度和强迫症症状尺寸的替代指标相关。从基线到随访，DY-BOCS的变化评分与强迫症替代措施和临床医师评价的改善的变化评分显着相关，这表明DY-BOCS的这一简短版本对治疗效果有效且敏感用于常规临床护理中的强迫症。

"点击查看英文标题和摘要"

Validation of an interview-only version of the Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS) in treatment-seeking youth with obsessive-compulsive disorder.

There is a growing body of evidence suggesting that individuals with obsessive-compulsive disorder (OCD) may be sub-typed along different symptom dimensions. These dimensions may help explain responsiveness to current treatments. The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS) is a validated instrument involving a self-report screening tool followed by a structured interview in which the presence/absence and severity of OCD symptom dimensions are assessed and rated. The present study investigated the validity of a briefer, interview-only version of the DY-BOCS modified for use in routine care. Clinically-referred children and adolescents (N = 119) with OCD were administered the DY-BOCS along with other measures of OCD, anxiety, depression, and overall functioning and a subset (N = 100) were reassessed on average 14 months after initial assessment. This briefer, interview-only version of the DY-BOCS demonstrated high levels of internal consistency and correlated in the moderate to strong range with alternative measures of OCD severity and OCD symptom dimensions. Change scores on the DY-BOCS from baseline to follow-up were significantly correlated with change scores on the alternative measures of OCD and clinician-rated improvement, suggesting that this brief version of the DY-BOCS is valid and sensitive to the effects of treatment for OCD delivered in routine clinical care.

更新日期：2019-11-01

点击分享查看原文

点击收藏

公开下载

阅读更多本刊新发论文本刊介绍/投稿指南